Diagonal Bio Financials
| DIABIO Stock | 0.03 0 4.98% |
Diagonal |
Understanding current and past Diagonal Bio Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Diagonal Bio's financial statements are interrelated, with each one affecting the others. For example, an increase in Diagonal Bio's assets may result in an increase in income on the income statement.
Please note, the presentation of Diagonal Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Diagonal Bio's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Diagonal Bio's management manipulating its earnings.
| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0015961826 |
| Business Address | The Spark, Lund, |
| Benchmark | Dow Jones Industrial |
| Website | diagonalbio.com |
| Phone | 46 7 35 26 27 59 |
You should never invest in Diagonal Bio without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Diagonal Stock, because this is throwing your money away. Analyzing the key information contained in Diagonal Bio's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Diagonal Bio Key Financial Ratios
Diagonal Bio's financial ratios allow both analysts and investors to convert raw data from Diagonal Bio's financial statements into concise, actionable information that can be used to evaluate the performance of Diagonal Bio over time and compare it to other companies across industries.Diagonal Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Diagonal Bio's current stock value. Our valuation model uses many indicators to compare Diagonal Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Diagonal Bio competition to find correlations between indicators driving Diagonal Bio's intrinsic value. More Info.Diagonal Bio AB is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Diagonal Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Diagonal Bio's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Diagonal Bio AB Systematic Risk
Diagonal Bio's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Diagonal Bio volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Diagonal Bio AB correlated with the market. If Beta is less than 0 Diagonal Bio generally moves in the opposite direction as compared to the market. If Diagonal Bio Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Diagonal Bio AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Diagonal Bio is generally in the same direction as the market. If Beta > 1 Diagonal Bio moves generally in the same direction as, but more than the movement of the benchmark.
Diagonal Bio November 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Diagonal Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Diagonal Bio AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Diagonal Bio AB based on widely used predictive technical indicators. In general, we focus on analyzing Diagonal Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Diagonal Bio's daily price indicators and compare them against related drivers.
| Downside Deviation | 8.22 | |||
| Information Ratio | 0.0749 | |||
| Maximum Drawdown | 162.09 | |||
| Value At Risk | (12.09) | |||
| Potential Upside | 16.67 |
Complementary Tools for Diagonal Stock analysis
When running Diagonal Bio's price analysis, check to measure Diagonal Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diagonal Bio is operating at the current time. Most of Diagonal Bio's value examination focuses on studying past and present price action to predict the probability of Diagonal Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diagonal Bio's price. Additionally, you may evaluate how the addition of Diagonal Bio to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |